Landec Corporation Sets Third Quarter 2022 Earnings Conference Call for April 5, 2022 at 2 p.m. PT

Rhea-AI Summary

Landec Corporation (Nasdaq: LNDC) will host a conference call to discuss its fiscal 2022 third quarter financial results on April 5, 2022, at 2:00 p.m. Pacific time. The call will cover financial metrics from the company's Lifecore Biomedical segment, a contract development and manufacturing organization specializing in sterile injectable pharmaceuticals. A live webcast will be available on Landec's website for 30 days following the event. For participants, dialing information is provided, along with a replay availability until April 12, 2022.

Positive

• Lifecore Biomedical is a leader in manufacturing injectable-grade Hyaluronic Acid.
• The company has 35 years of expertise in supporting biopharmaceutical innovations.

Negative

• None.

SANTA MARIA, Calif., March 22, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its growing Lifecore Biomedical (“Lifecore”) business – a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials – will host a conference call to discuss fiscal 2022 third quarter financial results. The live webcast can be accessed via Landec’s website on the Investor Events & Presentations page. The webcast will be available for 30 days.

Date: Tuesday, April 5, 2022

Time: 2:00 p.m. Pacific time (5:00 p.m. Eastern time)

Direct Webcast link: https://viavid.webcasts.com/starthere.jsp?ei=1537856&tp_key=3c4cdc0eb7

To participate in the conference call via telephone, dial toll-free: 1-877-407-3982 (U.S.) or 1-201-493-6780 (International). Please call the conference telephone number 5-10 minutes prior to the start time so the operator can register your name and organization.

A replay of the call will be available through Tuesday, April 12th, by calling toll-free: 1-844-512-2921 (U.S.) or 1-412-317-6671 (International), and entering code 13728030.

About Landec Corporation
Landec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Lifecore Biomedical, Inc. and Curation Foods, Inc. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels. Curation Foods brands include Yucatan® and Cabo Fresh® avocado products and O Olive Oil & Vinegar® premium artisan products. For more information about the Company, visit Landec’s website at www.landec.com.

Landec Corp. Contact Information:
Investor Relations
Jeff Sonnek
(646) 277-1263
jeff.sonnek@icrinc.com

FAQ

When will Landec Corporation discuss its Q3 2022 financial results?

Landec Corporation will discuss its Q3 2022 financial results on April 5, 2022, at 2:00 p.m. Pacific time.

How can I access the Landec Corporation conference call?

You can access the conference call via a live webcast on Landec's Investor Events & Presentations page.

What is Lifecore Biomedical known for?

Lifecore Biomedical is known for its contract development and manufacturing of complex sterile injectable pharmaceutical products.

What is the replay availability for the Landec conference call?

A replay of the call will be available until April 12, 2022.

What are the key segments of Landec Corporation?

Landec Corporation operates two main segments: Lifecore Biomedical and Curation Foods.